Related Experiment Videos
Synthesis and biological activity of novel thiazolidinediones
C Prabhakar1, G Madhusudhan, K Sahadev
1Department of Process Research and Development, Dr. Reddy's Research Foundation, Miyapur, Hyderabad, India.
Bioorganic & Medicinal Chemistry Letters
|January 5, 1999
Abstract:
Novel compounds having a dual pharmacophore were synthesised and evaluated for their insulin sensitiser and anti-inflammatory properties in different animal models.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Seasonal variations in sources of dissolved inorganic carbon in the Godavari estuary (India) using stable carbon isotopes.
Environmental science and pollution research international·2025
The black tears of USS Arizona: Forensic assessment of residual oil from the Pearl Harbor shipwreck.
Marine pollution bulletin·2025
Measurement of CP Violation in B^{0}→ψ(→ℓ^{+}ℓ^{-})K_{S}^{0}(→π^{+}π^{-}) Decays.
Physical review letters·2024
Precision Measurement of CP Violation in the Penguin-Mediated Decay B_{s}^{0}→ϕϕ.
Physical review letters·2023
Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer.
Bioorganic & medicinal chemistry letters·2026
Efficient PNA double-duplex invasion using preQ1•G-clamp as a pseudo-complementary G•C base pair.
Bioorganic & medicinal chemistry letters·2026
Reactivation of an inert 15-mer antimicrobial peptide by truncation-directed i, i + 7 lactam cyclization.
Bioorganic & medicinal chemistry letters·2026
Semi-synthesis and activity study of α-mangostin ether derivatives bearing N-heterocyclic side chains as multitarget-directed ligands against AD.
Bioorganic & medicinal chemistry letters·2026
Caffeic acid phenethyl ester derivatives inhibit glyoxalase I activity and induce cell death in cultured cancer cell lines.
Bioorganic & medicinal chemistry letters·2026
Acetazolamide use in idiopathic intracranial hypertension: a real-world cohort study of side effects.
Expert review of neurotherapeutics·2026